Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
2023年5月30日 - 9:30PM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever
Leaves”), a global medicinal cannabis company, announced today the
arrival of the company’s first shipment of medical cannabis
extracts from Colombia to Switzerland-based partner, Astrasana
Holding AG (“Astrasana”). This marks the first commercial shipment
for Clever Leaves to Switzerland, where Astrasana is an established
medical cannabis distributor.
Additionally, Clever Leaves and Astrasana are
preparing for the first shipment of medical cannabis extracts to
the Czech Republic, where Astrasana has pharmaceutical operations
and manages its own pharmacy specialising in the sale of medical
cannabis.
The supply agreement between Clever Leaves and
Astrasana will allow Clever Leaves to expand into new European
markets and further solidify its position as a global provider of
medical cannabis. Switzerland and the Czech Republic have both seen
recent legislative changes in favor of medical cannabis and are at
the forefront of the emerging European cannabis industry.
“The Supply Agreement guarantees Astrasana a
reliable and consistent supply of medical cannabis extracts at
competitive prices, providing planning certainty and allowing for
seamless operations,” says CEO of Astrasana Holding, Yves
Antoniazzi. “This partnership with Clever Leaves not only ensures a
steady supply of premium medical cannabis products for Astrasana's
customers, but also intensifies the existing collaboration between
the two companies, paving the way for future growth
opportunities.”
Clever Leaves, a publicly traded company with a
well-regarded reputation in the cannabis industry, has been
operating since 2016 and is known for its expertise in producing
high-quality medical cannabis extracts. The company's commitment to
upholding the highest standards in the industry aligns perfectly
with Astrasana's values and mission to provide safe and effective
medical cannabis products to patients worldwide.
"Clever Leaves' first commercial shipment of
medical cannabis extracts to Astrasana in Switzerland marks a
significant step towards our goal of expanding patient access to
high-quality medical cannabis across Europe and beyond. Through our
strategic partnership with Astrasana, we look forward to aligning
our capabilities and further penetrating new countries in Europe
such as Switzerland and Czech Republic. As a company, we remain
focused on driving innovation in the industry and creating safe,
pharmaceutical-grade products for patients in need,” said
Co-Founder and CEO of Clever Leaves, Andres Fajardo.
With Clever Leaves' global reach and expertise in the
cannabis industry, Astrasana is poised to further strengthen its
position as a leading provider and distributor of medical cannabis
in the Czech Republic and Switzerland.
About AstrasanaAstrasana is a
pioneering company in the field of medical cannabis, with
manufacturing and retail locations in the Czech Republic and
Switzerland. With comprehensive pharmaceutical licenses and a
strong focus on quality, sustainability, innovation, and customer
satisfaction, Astrasana is dedicated to providing safe and
effective medical cannabis products to patients. Astrasana's board
of directors consists of doctors and pharmacists which allow the
company to have a competitive advantage.
About Clever Leaves Holdings
Inc.Clever Leaves is a global medical cannabis company.
Its operations in Colombia produce EU GMP cannabinoid active
pharmaceutical ingredients (API) and finished products in flower
and extract form to a growing base of B2B customers around the
globe. Clever Leaves aims to disrupt the traditional cannabis
production industry by leveraging environmentally sustainable,
ESG-friendly, industrial-scale and low-cost production methods,
with the world’s most stringent pharmaceutical quality
certifications. For more information, please visit
https://cleverleaves.com/en/home/ and follow Clever Leaves on
Twitter and LinkedIn.
Clever Leaves Press Contacts:Maria PetsanasKCSA Strategic
Communications+1-917-692-6673 | cleverleaves@kcsa.com
Clever Leaves Investor Inquiries:Cody Slach and Jackie
KeshnerGateway Group, Inc.+1-949-574-3860 | CLVR@gatewayir.com
Clever Leaves Commercial Contact:Andrew MillerHead of Global
Business Developmentandrew.miller@cleverleaves.com+1
416-817-1336
Clever Leaves (NASDAQ:CLVR)
過去 株価チャート
から 5 2024 まで 6 2024
Clever Leaves (NASDAQ:CLVR)
過去 株価チャート
から 6 2023 まで 6 2024